Elevance Health, Inc. (LON:0HG8)

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of GBP 53.64 billion. The enterprise value is 71.50 billion.

Market Cap	53.64B
Enterprise Value	71.50B

Important Dates

The last earnings date was Wednesday, October 15, 2025.

Earnings Date	Oct 15, 2025
Ex-Dividend Date	Sep 10, 2025

Share Statistics

Current Share Class	222.24M
Shares Outstanding	n/a
Shares Change (YoY)	-3.08%
Shares Change (QoQ)	-0.93%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	94.35%
Float	221.77M

Valuation Ratios

The trailing PE ratio is 13.03 and the forward PE ratio is 11.81.

PE Ratio	13.03
Forward PE	11.81
PS Ratio	0.37
PB Ratio	1.64
P/TBV Ratio	17.27
P/FCF Ratio	19.14
P/OCF Ratio	14.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.33, with an EV/FCF ratio of 25.51.

EV / Earnings	17.37
EV / Sales	0.48
EV / EBITDA	10.33
EV / EBIT	11.59
EV / FCF	25.51

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.73.

Current Ratio	1.56
Quick Ratio	1.43
Debt / Equity	0.73
Debt / EBITDA	3.52
Debt / FCF	8.52
Interest Coverage	5.90

Financial Efficiency

Return on equity (ROE) is 12.57% and return on invested capital (ROIC) is 6.89%.

Return on Equity (ROE)	12.57%
Return on Assets (ROA)	4.24%
Return on Invested Capital (ROIC)	6.89%
Return on Capital Employed (ROCE)	9.92%
Revenue Per Employee	1.39M
Profits Per Employee	39,503
Employee Count	104,200
Asset Turnover	1.63
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 1.17 billion in taxes.

Income Tax	1.17B
Effective Tax Rate	22.15%

Stock Price Statistics

The stock price has decreased by -27.02% in the last 52 weeks. The beta is 0.53, so Elevance Health's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-27.02%
50-Day Moving Average	329.50
200-Day Moving Average	365.35
Relative Strength Index (RSI)	33.73
Average Volume (20 Days)	1,369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.41

Income Statement

In the last 12 months, Elevance Health had revenue of GBP 144.93 billion and earned 4.12 billion in profits. Earnings per share was 18.14.

Revenue	144.93B
Gross Profit	38.06B
Operating Income	6.04B
Pretax Income	5.28B
Net Income	4.12B
EBITDA	6.64B
EBIT	6.04B
Earnings Per Share (EPS)	18.14

Balance Sheet

The company has 26.94 billion in cash and 23.88 billion in debt, giving a net cash position of -17.40 billion.

Cash & Cash Equivalents	26.94B
Total Debt	23.88B
Net Cash	-17.40B
Net Cash Per Share	n/a
Equity (Book Value)	32.79B
Book Value Per Share	147.27
Working Capital	17.04B

Cash Flow

In the last 12 months, operating cash flow was 3.65 billion and capital expenditures -851.81 million, giving a free cash flow of 2.80 billion.

Operating Cash Flow	3.65B
Capital Expenditures	-851.81M
Free Cash Flow	2.80B
FCF Per Share	n/a

Margins

Gross margin is 26.26%, with operating and profit margins of 4.17% and 2.84%.

Gross Margin	26.26%
Operating Margin	4.17%
Pretax Margin	3.64%
Profit Margin	2.84%
EBITDA Margin	4.58%
EBIT Margin	4.17%
FCF Margin	1.93%

Dividends & Yields

This stock pays an annual dividend of 5.13, which amounts to a dividend yield of 1.64%.

Dividend Per Share	5.13
Dividend Yield	1.64%
Dividend Growth (YoY)	3.11%
Years of Dividend Growth	7
Payout Ratio	28.29%
Buyback Yield	3.08%
Shareholder Yield	4.72%
Earnings Yield	7.67%
FCF Yield	5.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5